Aspirin Use Behind Trump’s Hand Bruising, Aide Confirms

Aspirin Use Behind Trump’s Hand Bruising, Aide Confirms Aspirin Use Behind Trump’s Hand Bruising, Aide Confirms

President Donald Trump has disclosed that his use of a higher-than-recommended aspirin dosage is responsible for the visible bruising noticed on his hands in recent public appearances.

Eko Hot News reports that Trump explained he takes 325 milligrams of aspirin daily, exceeding the commonly prescribed low-dose aspirin, which is typically around 81 milligrams. He said the decision is based on his personal belief that the regimen helps maintain good blood flow and supports heart health.

Aspirin Use Behind Trump’s Hand Bruising, Aide Confirms

The former president acknowledged that aspirin’s blood-thinning properties, combined with frequent handshakes during public engagements, have contributed to the noticeable marks on his hands. The explanation follows weeks of speculation and commentary on social media and in the press regarding his physical condition.

Medical professionals familiar with aspirin therapy note that higher doses can make the skin more prone to bruising, particularly in older adults. Such effects are generally not unusual for individuals on long-term blood-thinning medication.

Aspirin Use Behind Trump’s Hand Bruising, Aide Confirms

Trump’s physician reportedly confirmed that the bruising is consistent with aspirin use and routine physical contact. The doctor also stated that recent medical evaluations showed no serious underlying cardiovascular issues.

Despite suggestions that he reduce the dosage, Trump has indicated reluctance to change a routine he has followed for years. He maintains that he feels healthy and capable, dismissing concerns about his stamina or overall well-being.

The discussion has once again drawn public attention to the health of senior political figures and the level of scrutiny surrounding their medical choices. Observers say the episode highlights the broader debate on transparency and personal health management among leaders in the public eye.